Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)
Clinical trial NCT05464381 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05464381
- Sponsor
- RHEACELL GmbH & Co. KG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2025-08-29
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.